Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek A Wainwright

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Journal of Hematology & Oncology|June 11, 2020
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapyFahmin Basher, Payal Dhar, Xin Wang, et al.
Biological Research for Nursing|July 1, 2020
Systematic Review of the Kynurenine Pathway and Psychoneurological Symptoms Among Adult Cancer SurvivorsHongjin Li, Tingting Liu, Lacey W Heinsberg, et al.
Clinical Lung Cancer|September 9, 2020
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint InhibitorsMichael S Oh, Alex Guzner, Derek A Wainwright, et al.
Journal of Neuroimmunology|November 26, 2013
Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor modelMahua Dey, Alan L Chang, Derek A Wainwright, et al.
Neuroscience Letters|August 6, 2016
Advanced age negatively impacts survival in an experimental brain tumor modelErik Ladomersky, Lijie Zhai, Galina Gritsina, et al.
Oncoimmunology|July 30, 2016
Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimuriumDavid C Binder, Ainhoa Arina, Frank Wen, et al.
Cancers|January 8, 2025
Immune Checkpoint Inhibitors in Glioblastoma IDHwt Treatment: A Systematic ReviewArchit Bharathwaj Baskaran, Olivia A Kozel, Omkar Venkatesh, et al.
ASN Neuro|November 20, 2009
Exacerbation of facial motoneuron loss after facial nerve axotomy in CCR3-deficient miceDerek A Wainwright, Junping Xin, Nichole A Mesnard, et al.
Journal of Neuro-Oncology|December 19, 2014
The role of IDO in brain tumor immunotherapyLijie Zhai, Kristen L Lauing, Alan L Chang, et al.
Cancers|August 26, 2022
Next Steps for Immunotherapy in GlioblastomaToni Q Cao, Derek A Wainwright, Catalina Lee-Chang, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Journal of Hematology & Oncology|June 11, 2020
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapyFahmin Basher, Payal Dhar, Xin Wang, et al.
Biological Research for Nursing|July 1, 2020
Systematic Review of the Kynurenine Pathway and Psychoneurological Symptoms Among Adult Cancer SurvivorsHongjin Li, Tingting Liu, Lacey W Heinsberg, et al.
Clinical Lung Cancer|September 9, 2020
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint InhibitorsMichael S Oh, Alex Guzner, Derek A Wainwright, et al.
Journal of Neuroimmunology|November 26, 2013
Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor modelMahua Dey, Alan L Chang, Derek A Wainwright, et al.
Neuroscience Letters|August 6, 2016
Advanced age negatively impacts survival in an experimental brain tumor modelErik Ladomersky, Lijie Zhai, Galina Gritsina, et al.
Oncoimmunology|July 30, 2016
Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimuriumDavid C Binder, Ainhoa Arina, Frank Wen, et al.
Cancers|January 8, 2025
Immune Checkpoint Inhibitors in Glioblastoma IDHwt Treatment: A Systematic ReviewArchit Bharathwaj Baskaran, Olivia A Kozel, Omkar Venkatesh, et al.
ASN Neuro|November 20, 2009
Exacerbation of facial motoneuron loss after facial nerve axotomy in CCR3-deficient miceDerek A Wainwright, Junping Xin, Nichole A Mesnard, et al.
Journal of Neuro-Oncology|December 19, 2014
The role of IDO in brain tumor immunotherapyLijie Zhai, Kristen L Lauing, Alan L Chang, et al.
Cancers|August 26, 2022
Next Steps for Immunotherapy in GlioblastomaToni Q Cao, Derek A Wainwright, Catalina Lee-Chang, et al.
Pageof 9